Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product

PURPOSE: Filgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired neutropenia. Following patent expiration of the innovator filgrastim product, biosimilar filgrastim products have been approved in the EU and shown to be comparable with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Halim, Liem Andhyk, Márquez, Maripaz, Maas-Bakker, Roel F., Castañeda-Hernández, Gilberto, Jiskoot, Wim, Schellekens, Huub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182392/
https://www.ncbi.nlm.nih.gov/pubmed/30280277
http://dx.doi.org/10.1007/s11095-018-2491-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182392/
https://www.ncbi.nlm.nih.gov/pubmed/30280277
http://dx.doi.org/10.1007/s11095-018-2491-5

Ejemplares similares